Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Valneva SE - American Depositary Shares
(NQ:
VALN
)
8.940
-0.240 (-2.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Valneva SE - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
EHang, Molecular Partners And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
August 26, 2025
Via
Benzinga
Crude Oil Surges 2%; Chicago Fed National Activity Index Edges Lower in July
August 25, 2025
Via
Benzinga
Topics
Economy
Valneva Stock Tumbles 19% After FDA Suspension Of Ixchiq License In US, Wall Street Divided On The Impact
August 25, 2025
Via
Stocktwits
12 Health Care Stocks Moving In Monday's Intraday Session
August 25, 2025
Via
Benzinga
Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday
August 25, 2025
Via
Benzinga
Earnings Scheduled For May 7, 2025
May 07, 2025
Via
Benzinga
Insights Ahead: Valneva's Quarterly Earnings
May 06, 2025
Via
Benzinga
4 Analysts Have This To Say About Valneva
February 19, 2025
Via
Benzinga
Safety Concerns Hit Valneva As Ixchiq Chikungunya Virus Vaccine Is Suspended In US
August 25, 2025
Valneva shares fall after FDA suspends Ixchiq vaccine license citing new safety reports, raising questions over future U.S. sales and regulatory review.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 25, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 13, 2025
Via
Benzinga
GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday
July 23, 2025
Via
Benzinga
Expert Ratings For Valneva
October 11, 2024
Via
Benzinga
In-Depth Examination Of 6 Analyst Recommendations For Valneva
September 25, 2024
Via
Benzinga
Earnings Scheduled For August 12, 2025
August 12, 2025
Via
Benzinga
MP Materials, CoreWeave, Trade Desk And Other Big Stocks Moving Higher On Tuesday
July 15, 2025
Via
Benzinga
Valneva's Chikungunya Vaccine Advances With Pediatric Trial, Phase 3 In 2026
June 05, 2025
Valneva reports positive six-month data for Ixchiq in children, supporting a full dose approach ahead of a Phase 3 trial set for early 2026.
Via
Benzinga
US Health Agencies Recommend Pausing Valneva's Chikungunya Vaccine For Older Adults After Adverse Events
May 12, 2025
FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including deaths, trigger a new safety assessment.
Via
Benzinga
Topics
Death
12 Analysts Assess Valneva: What You Need To Know
April 15, 2025
Via
Benzinga
Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine
April 14, 2025
Valneva's chikungunya vaccine Ixchiq receives Brazil approval, enabling expanded trials and access across Latin America and endemic regions.
Via
Benzinga
Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday
April 03, 2025
Via
Benzinga
Breaking Down Valneva: 6 Analysts Share Their Views
March 21, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 31, 2025
Via
Benzinga
Earnings Scheduled For March 20, 2025
March 20, 2025
Via
Benzinga
Valneva Vaccine Shows Sustained Immune Response In Adolescents One Year After Single Shot
January 21, 2025
Valneva chikungunya vaccine shows strong, sustained immune response in adolescents, supporting potential approvals in Brazil and other regions.
Via
Benzinga
Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday
December 19, 2024
Via
Benzinga
Valneva's Chikungunya Shot Shows Strong, Long-Lasting Antibody Persistence At Three Years, Comparable In Older And Younger Adults
December 03, 2024
Valneva reports long-lasting antibody persistence in its chikungunya vaccine three years post-dose, supporting its global approvals and expansion efforts.
Via
Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
November 15, 2024
Vaccine stocks react to Robert F. Kennedy Jr.'s HHS nomination. FDA and NIH express concerns over his anti-vaccine views amid market shifts.
Via
Benzinga
Palo Alto Networks To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
October 11, 2024
Via
Benzinga
Adobe, SelectQuote, Similarweb And Other Big Stocks Moving Lower In Friday's Pre-Market Session
September 13, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.